Results and complications of high dose rate and low dose rate brachytherapy in carcinoma of the cervix: Cerrahpaşa experience. (Q52016473)

19 April 2018

title

Results and complications of high dose rate and low dose rate brachytherapy in carcinoma of the cervix: Cerrahpaşa experience. (English)

1 reference

19 April 2018

1 reference

Sait Okkan

1

1 reference

19 April 2018

Gülyüz Atkovar

2

1 reference

19 April 2018

Ismet Sahinler

3

1 reference

19 April 2018

Fazilet Oner Dinçbaş

4

1 reference

19 April 2018

Ayşe Koca

5

1 reference

19 April 2018

Selçuk Köksal

6

1 reference

19 April 2018

Sedat Turkan

7

1 reference

19 April 2018

Reha Uzel

8

1 reference

19 April 2018

publication date

1 April 2003

1 reference

19 April 2018

Radiotherapy and Oncology

published in

1 reference

19 April 2018

volume

67

1 reference

19 April 2018

issue

1

1 reference

19 April 2018

page(s)

97-105

1 reference

19 April 2018

High-dose-rate remote afterloading intracavitary radiation therapy for cancer of the uterine cervix. A 20-year experience

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900030-6

7 January 2021

Impact on treatment outcome and late effects of customized treatment planning in cervix carcinomas: baseline results to compare new strategies.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900030-6

7 January 2021

The significance of anemia in clinical radiation therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900030-6

7 January 2021

Rectal complications in patients with carcinoma of the cervix treated with concomitant cisplatin and external beam irradiation with high dose rate brachytherapy: a dosimetric analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900030-6

7 January 2021

The prediction of late rectal complications in patients treated with high dose-rate brachytherapy for carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900030-6

7 January 2021

Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900030-6

7 January 2021

High-dose-rate brachytherapy for carcinoma of the cervix: high tech or high risk?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900030-6

7 January 2021

Time course and incidence of late complications in patients treated with radiation therapy for FIGO Stage IB carcinoma of the uterine cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900030-6

7 January 2021

High-dose-rate brachytherapy in the treatment of uterine cervix cancer. Analysis of dose effectiveness and late complications

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900030-6

7 January 2021

High-dose-rate versus low-dose-rate intracavitary brachytherapy for carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900030-6

7 January 2021

Prognostic factors in patients with cervix cancer treated by radiation therapy: results of a multiple regression analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900030-6

7 January 2021

The treatment of uterine carcinoma using the Cathetron. Part III. Clinical considerations and preliminary reports on treatment results.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900030-6

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900030-6

7 January 2021

Pretreatment prognostic factors in carcinoma of the uterine cervix: a multivariable analysis of the effect of age, stage, histology and blood counts on survival

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900030-6

7 January 2021

Carcinoma of the cervix: analysis of complications after primary external beam radiation and Ir-192 HDR brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900030-6

7 January 2021

Prognostic factors in patients with carcinoma of the uterine cervix treated with external beam irradiation and IR-192 high-dose-rate brachytherapy

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900030-6

7 January 2021

High-dose-rate afterloading brachytherapy in carcinoma of the cervix: an experience of 1992 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900030-6

7 January 2021

The American Brachytherapy Society recommendations for high-dose-rate brachytherapy for carcinoma of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900030-6

7 January 2021

Late rectal complication following high dose rate intracavitary brachytherapy in cancer of the cervix

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900030-6

7 January 2021

Comparison of high and low dose rate remote afterloading for cervix cancer and the importance of fractionation.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900030-6

7 January 2021

Low dose rate vs. high dose rate brachytherapy in the treatment of carcinoma of the uterine cervix: a clinical trial

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900030-6

7 January 2021

Irradiation alone or combined with surgery in stage IB, IIA, and IIB carcinoma of uterine cervix: update of a nonrandomized comparison

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900030-6

7 January 2021

Radiation therapy morbidity in carcinoma of the uterine cervix: dosimetric and clinical correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900030-6

7 January 2021

Literature analysis of high dose rate brachytherapy fractionation schedules in the treatment of cervical cancer: is there an optimal fractionation schedule?

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900030-6

7 January 2021

High-dose-rate versus low-dose-rate brachytherapy in the treatment of cervical cancer: analysis of tumor recurrence--the University of Wisconsin experience

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900030-6

7 January 2021

Design and analysis of randomized clinical trials requiring prolonged observation of each patient. II. analysis and examples

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900030-6

7 January 2021

Treatment results of high dose rate brachytherapy in patients with carcinoma of the cervix.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900030-6

7 January 2021

Treatment of carcinoma of the uterine cervix by remotely controlled afterloading intracavitary radiotherapy with high-dose rate: a comparative study with a low-dose rate system

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900030-6

7 January 2021

High-dose rate and low-dose rate intracavitary therapy for carcinoma of the uterine cervix. Final results of Osaka University Hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0167-8140%2803%2900030-6

7 January 2021

10.1016/S0167-8140(03)00030-6

Identifiers

DOI

1 reference

19 April 2018

1 reference

19 April 2018